Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;16(3):716-723.
doi: 10.1177/1932296820985567. Epub 2021 Jan 12.

Diabetic Retinopathy Screening Using Artificial Intelligence and Handheld Smartphone-Based Retinal Camera

Affiliations

Diabetic Retinopathy Screening Using Artificial Intelligence and Handheld Smartphone-Based Retinal Camera

Fernando Korn Malerbi et al. J Diabetes Sci Technol. 2022 May.

Abstract

Background: Portable retinal cameras and deep learning (DL) algorithms are novel tools adopted by diabetic retinopathy (DR) screening programs. Our objective is to evaluate the diagnostic accuracy of a DL algorithm and the performance of portable handheld retinal cameras in the detection of DR in a large and heterogenous type 2 diabetes population in a real-world, high burden setting.

Method: Participants underwent fundus photographs of both eyes with a portable retinal camera (Phelcom Eyer). Classification of DR was performed by human reading and a DL algorithm (PhelcomNet), consisting of a convolutional neural network trained on a dataset of fundus images captured exclusively with the portable device; both methods were compared. We calculated the area under the curve (AUC), sensitivity, and specificity for more than mild DR.

Results: A total of 824 individuals with type 2 diabetes were enrolled at Itabuna Diabetes Campaign, a subset of 679 (82.4%) of whom could be fully assessed. The algorithm sensitivity/specificity was 97.8 % (95% CI 96.7-98.9)/61.4 % (95% CI 57.7-65.1); AUC was 0·89. All false negative cases were classified as moderate non-proliferative diabetic retinopathy (NPDR) by human grading.

Conclusions: The DL algorithm reached a good diagnostic accuracy for more than mild DR in a real-world, high burden setting. The performance of the handheld portable retinal camera was adequate, with over 80% of individuals presenting with images of sufficient quality. Portable devices and artificial intelligence tools may increase coverage of DR screening programs.

Keywords: Covid-19; artificial intelligence; diabetic retinopathy; mobile healthcare; point-of-care; screening; telemedicine.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: JAS is Chief Executive Officer and proprietary of Phelcom Technologies. DL is Chief Technology Officer and proprietary of Phelcom Technologies. JVP has a research scholarship conducted at Phelcom Technologies

Figures

Figure 1.
Figure 1.
Example of heatmap visualization using gradient method. (a) Color fundus photograph depicting hard exudates and microaneurysms in the macular region, suggesting the possibility of diabetic macular oedema. (b) Overlay with the GradCam heatmap visualization can aid in making a diagnosis as the modifications are flagged in a color scale, from blue (low importance) to red (high importance).
Figure 2.
Figure 2.
Waterfall diagram. Standards for Reporting of Diagnostic Accuracy Studies (STARD) diagram for the algorithm mtmDR output. mtmDR, more than mild diabetic retinopathy.
Figure 3.
Figure 3.
Receiver operating characteristic (ROC) curve of the artificial intelligence device for detection of more than mild diabetic retinopathy (mtmDR). Area under the curve = 0.89.
Figure 4.
Figure 4.
Example of a false positive case. (a) Color fundus photograph depicting inferior pigmentary change. (b) Overlay with the GradCam heatmap; the pigmentary alteration is flagged by the algorithm, leading to a false positive output.

References

    1. Klonoff DC, Schwartz DM. An economic analysis of interventions for diabetes. Diabetes Care. 2000;23:390-404. - PubMed
    1. Scanlon PH. The English national screening programme for diabetic retinopathy 2003–2016. Acta Diabetol. 2017;54:515-525. - PMC - PubMed
    1. Wong TY, Sun J, Kawasaki R, et al.. Guidelines on diabetic eye care. The international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018;125:1608-1622. - PubMed
    1. Vujosevic S, Aldington SJ, Silva P, et al.. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020;8:337-347. - PubMed
    1. Shah A, Clarida W, Amelon R, et al.. Validation of automated screening for referable diabetic retinopathy with an autonomous diagnostic artificial intelligence system in a Spanish population [published online ahead of print March 16, 2020. J Diabetes Sci Technol. doi:10.1177/1932296820906212 - DOI - PMC - PubMed

Publication types